Bryan K S Yeung

Title: Innovations of Bryan K S Yeung

Introduction

Bryan K S Yeung is a notable inventor based in Singapore, SG. He has made significant contributions to the field of biotechnology, particularly in the development of compounds that modulate protein kinase activity. With a total of 3 patents to his name, Yeung's work is pivotal in addressing kinase-dependent diseases.

Latest Patents

Yeung's latest patents include "Pyrazole kinase modulators and methods of use." This invention provides compounds that modulate protein kinase enzymatic activity, influencing cellular activities such as proliferation, differentiation, programmed cell death, migration, and chemoinvasion. The compounds are designed to inhibit, regulate, and modulate kinases, offering methods for treating various diseases and conditions. Another significant patent is "Pyridopyrimidinone inhibitors of PI3Kα for the treatment of cancer." This invention focuses on compounds of Formula I and their pharmaceutically acceptable salts or solvates, along with methods for their production and application.

Career Highlights

Bryan K S Yeung is currently associated with Exelixis, Inc., where he continues to innovate in the field of cancer treatment and kinase modulation. His work is characterized by a strong emphasis on developing therapeutic solutions that can significantly impact patient care.

Collaborations

Yeung collaborates with esteemed colleagues such as Tae-Gon Baik and Chris Allen Buhr, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Bryan K S Yeung's contributions to biotechnology through his patents and collaborative efforts highlight his role as a leading inventor in the field. His work continues to pave the way for advancements in the treatment of kinase-dependent diseases.